Q/C Technologies, Inc. (QCLS)
1.79
-0.09
(-4.79%)
USD |
NASDAQ |
Sep 04, 16:00
1.78
-0.01
(-0.56%)
After-Hours: 20:00
Q/C Technologies Enterprise Value : 7.171M for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 7.171M |
| September 03, 2026 | 7.908M |
| September 02, 2026 | 8.154M |
| September 01, 2026 | 9.628M |
| August 31, 2026 | 11.51M |
| August 28, 2026 | 11.76M |
| August 27, 2026 | 11.92M |
| August 26, 2026 | 12.90M |
| August 25, 2026 | 12.49M |
| August 24, 2026 | 12.25M |
| August 21, 2026 | 13.64M |
| August 20, 2026 | 14.87M |
| August 19, 2026 | 14.54M |
| August 18, 2026 | 14.54M |
| August 17, 2026 | 15.52M |
| August 14, 2026 | 15.20M |
| August 13, 2026 | 15.93M |
| August 12, 2026 | 16.18M |
| August 11, 2026 | 16.18M |
| August 10, 2026 | 15.61M |
| August 07, 2026 | 16.43M |
| August 06, 2026 | 15.44M |
| August 05, 2026 | 16.67M |
| August 04, 2026 | 16.51M |
| August 03, 2026 | 15.03M |
| Date | Value |
|---|---|
| July 31, 2026 | 13.89M |
| July 30, 2026 | 14.71M |
| July 29, 2026 | 13.07M |
| July 28, 2026 | 15.77M |
| July 27, 2026 | 18.88M |
| July 24, 2026 | 18.96M |
| July 23, 2026 | 19.95M |
| July 22, 2026 | 19.62M |
| July 21, 2026 | 20.44M |
| July 20, 2026 | 20.77M |
| July 17, 2026 | 20.68M |
| July 16, 2026 | 19.54M |
| July 15, 2026 | 21.01M |
| July 14, 2026 | 20.77M |
| July 13, 2026 | 20.60M |
| July 10, 2026 | 22.08M |
| July 09, 2026 | 22.98M |
| July 08, 2026 | 22.49M |
| July 07, 2026 | 22.57M |
| July 06, 2026 | 24.04M |
| July 02, 2026 | 24.04M |
| July 01, 2026 | 24.94M |
| June 30, 2026 | 24.45M |
| June 29, 2026 | 19.20M |
| June 26, 2026 | 18.26M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.871B |
| Corcept Therapeutics, Inc. | 11.75B |
| Veru, Inc. | 21.90M |
| Johnson & Johnson | 691.09B |
| Eli Lilly & Co. | 1.128T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.616M |
| Total Expenses (Quarterly) | 6.616M |
| EPS Diluted (Quarterly) | -0.794 |
| Earnings Yield | -242.5% |
| Normalized Earnings Yield | -190.84 |